[A new anti-cancer agent K-18 (conjugate of human IgG and melphalan). (II). Its inhibitory effects on in vitro DNA synthesis of human tumor cells].
D000970:Antineoplastic Agents / Q000494:pharmacology*; D002478:Cells, Cultured; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D004317:Doxorubicin / Q000494:pharmacology; D006801:Humans; D007074:Immunoglobulin G / Q000494:pharmacology; D008558:Melphalan / Q000494:pharmacology; D016685:Mitomycin; D008937:Mitomycins / Q000494:pharmacology; D009369:Neoplasms / Q000378:metabolism*
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D007074:Immunoglobulin G; D008937:Mitomycins; C051713:antineoplastic agent K 18; D016685:Mitomycin; D004317:Doxorubicin; D008558:Melphalan